Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wyeth was a prominent global pharmaceutical company that operated for nearly 150 years before its acquisition by Pfizer in 2009. Originally established as John Wyeth & Brother in 1860, the company became a leader in several therapeutic areas, including vaccines, oncology, and women's health. It was responsible for developing and marketing high-profile products such as the pneumococcal vaccine Prevnar and the blockbuster biologic Enbrel. The company's legacy includes significant contributions to the development of modern drug manufacturing and large-scale vaccine production. Today, its former assets and research programs are fully integrated into Pfizer's global operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on John Wyeth.